Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EBOS Group.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: All looking good on the ground for ASX health stocks
News
Pampered pooches: Which ASX stocks are riding the ‘humanisation of pets’ trend?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks seek some end of year love
Health & Biotech
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Health & Biotech
ASX Health Stocks: 2 immunotherapy biotechs announce progress on clinical trials
Experts
ScoPo’s Powerplays: Who’s pulling for a health sector recovery?
Health & Biotech
ASX Health Stocks: Healthcare index surges as CSL revels in blood plasma boom
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
Health & Biotech
ASX Health Stocks: Aussie biotechs Argenica and Antisense take major steps in the US
News
Here are the top ASX large cap movers for Wednesday
Health & Biotech
ScoPo’s Powerplays: Recent price swings uncovered hidden gems and buying opportunities in healthcare
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Health & Biotech
ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
Health & Biotech
ScoPo’s Powerplays: Smaller capped health stocks are still in ‘no man’s land’, but Neuren jumps 18pc this week
Health & Biotech